Bayer's $400M Cipro Payout Strangled Market, Consumers Say
A class of consumers argued before California's highest court last week that Bayer AG's $400 million pay-for-delay patent settlement preventing Barr Pharmaceuticals Inc. from selling its generic version of the antibiotic...To view the full article, register now.
Already a subscriber? Click here to view full article